# Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga

Study · id `cardio:ct-nct02561130` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02561130](<https://clinicaltrials.gov/study/NCT02561130>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02561130

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 154 participants.

## Technical summary

Registry record NCT02561130. Randomized; no masking; primary purpose treatment. Start 2015-12 (actual); primary completion 2017-07 (actual). Results posted on 2020-11-24.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 154 participants (enrolled count; ClinicalTrials.gov record NCT02561130, source copy `cardio:ctgov-nct02561130-2020-11-24`, retrieved 2026-10-26)
- Started: 2015-12 (actual) (ClinicalTrials.gov record NCT02561130, source copy `cardio:ctgov-nct02561130-2020-11-24`, retrieved 2026-10-26)
- Primary completion: 2017-07 (actual) (ClinicalTrials.gov record NCT02561130, source copy `cardio:ctgov-nct02561130-2020-11-24`, retrieved 2026-10-26)
- Completion: 2018-12-31 (actual) (ClinicalTrials.gov record NCT02561130, source copy `cardio:ctgov-nct02561130-2020-11-24`, retrieved 2026-10-26)
- Results first posted: 2020-11-24 (ClinicalTrials.gov record NCT02561130, source copy `cardio:ctgov-nct02561130-2020-11-24`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT02561130, source copy `cardio:ctgov-nct02561130-2020-11-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02561130-2020-11-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Remission Evaluation of a Metabolic Intervention in Type 2 Diabetes With Forxiga
- Condition: Type 2 Diabetes Mellitus
- Intervention (Drug): insulin glargine
- Intervention (Drug): metformin
- Intervention (Drug): Forxiga
- Intervention (Behavioral): Lifestyle therapy
- Lead sponsor: Population Health Research Institute
- Lead sponsor class: OTHER
- Collaborator: AstraZeneca
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Population Health Research Institute (`cardio:org-population-health-research-institute`)
- Registry lists this organization as a collaborator: AstraZeneca (`cardio:astrazeneca`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin (`cardio:pubmed-32403130`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 7e452af9e88b4e47501bfa4925d41869fc608d15d6166b10d639b0401a004618
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
